Effect of Macrolide Resistance and Mycoplasma pneumoniae DNA Load in Bronchoalveolar Lavage Fluid on Immune and Inflammatory Responses in Children with Mycoplasma pneumoniae Pneumonia [0.03%]
肺炎支原体DNA负荷及大环内酯耐药对支原体肺炎儿童免疫炎症反应的影响
Haiqin Zhong,Zeyu Zeng,Haoxiang Gu et al.
Haiqin Zhong et al.
Objective: To investigate the impact of macrolide resistance and Mycoplasma pneumoniae DNA (MP-DNA) load in bronchoalveolar lavage fluid (BALF) on immune and inflammatory responses in children with Mycoplasma pneumoniae p...
Intrapartum Antibiotics and Neonatal Sepsis: Confounding by Indication [0.03%]
产时使用抗生素和新生儿败血症：因指示造成的混杂因素
Deepak Chawla
Deepak Chawla
Neeraj Sharma,Robin Chaudhary,Puneet Saxena
Neeraj Sharma
Silent Bowel Damage From Magnetic Ball Ingestion: A Pediatric Case Series [0.03%]
磁球吞食致隐匿性肠道损伤的儿科病例报告
K R Aparna,M G Joy,Robin Thomas et al.
K R Aparna et al.
Ankita G Sharma,Preeti Singh
Ankita G Sharma
A Rare Cause of Pancytopenia in a Young Child: Infantile-Onset Multisystem Autoimmune Disease Type 1 [0.03%]
儿童全血细胞减少症的罕见原因：婴儿期起病多系统自身免疫疾病1型
Tuphan Kanti Dolai,Kaustav Ghosh
Tuphan Kanti Dolai
Impact of Biologic Therapy, School Success, Parent's Education and Socioeconomic Status on Transition Readiness in Adolescents with Juvenile Idiopathic Arthritis and Their Parents [0.03%]
生物制剂、学校成就、家长教育和经济社会地位对青少年强直性脊柱炎及其父母过渡准备的影响
Dragana Lazarević,Hristina Stamenković,Tatjana Stanković et al.
Dragana Lazarević et al.
Objective: To evaluate the effect of biologic therapy, school success, parental education and socioeconomic status on transition readiness of adolescent patients with juvenile idiopathic arthritis (JIA) and their parents....
Pulkit Agarwal
Pulkit Agarwal
Kalyana Prabhakaran,Jagdish Prasad Goyal
Kalyana Prabhakaran
H-ER-O-S: A Quality Improvement Initiative to Reduce Ventilator-Associated Pneumonia in a Level IIIb Neonatal Intensive Care Unit of a Tertiary Care Public Hospital [0.03%]
减少三级保健公立医院IIIb层新生儿重症监护病房呼吸机相关性肺炎的发生率的品质改进倡议-H-ER-O-S项目
Shaik Mohammed Munthakheem,Amol Kalyanrao Joshi,Laxmikant Sheshrao Deshmukh et al.
Shaik Mohammed Munthakheem et al.
Objective: To reduce the ventilator-associated pneumonia (VAP) rate by improving the compliance of components of the VAP prevention bundle to > 90% over a period of 35 weeks. ...